Supporting our Members with Asthma & COPD | Prime Therapeutics - Prime Therapeutics
Support your members with asthma and COPD
Learn more about asthma and COPD
Asthma causes wheezing, breathlessness, chest tightness and coughing at night or early in the morning. If you have asthma, you have it all the time, but you will have asthma attacks only when something bothers your lungs.1 COPD prevents airflow to the lungs, causing breathing problems. The most common COPD types are emphysema and chronic bronchitis. Nearly 16 million U.S. adults have COPD, and many more do not know they have it.2
1 in 20
1 in 20 of Prime’s commercially insured members had an asthma or COPD drug claim in the past quarter.3
16
Asthma/COPD drugs are the 16th most expensive drug category based on Prime’s combined commercial medical and pharmacy claims data.3
74%
Among members using an asthma or COPD specialty drug, these drug costs account for 74% of their total cost of care.4
1/2
Specialty asthma drug therapy adherence is poor. Half of members were not adherent six months after starting therapy.4
A comprehensive approach to savings
Proactive education
Gain peace of mind that providers, pharmacies and groups have received education on program policies and goals prior to launch.
Clinical rigor
Utilization management (UM) reviews help ensure appropriate use and collection of key clinical information, enforcement of assay and inventory management and dose optimization.
Personalized care
Provide customized guidance from our team of professionals, who simplify the experience for your members with personalized support.
Deep insights
Our data-driven insights identify trends to improve overall health outcomes and cost savings.
Choose what works best for you and your members
Footnotes
*All brand names are property of their respective owners.
**The programs listed are not available to all clients. Please check with your representative if you are interested in learning more.
1 About asthma. (2024, January 22). Asthma. https://www.cdc.gov/asthma/about/index.html
2 About COPD. (2024, May 15). Chronic Obstructive Pulmonary Disease (COPD). https://www.cdc.gov/copd/about/index.html
3 Internal analysis, 2024. Excludes Dupixent & Xolair use for treatment of asthma.
4 Prime Therapeutics LLC. (2022a, July 28). Study finds number of asthma biologic medication users and spend doubled over 2.5 years - Prime Therapeutics LLC. https://www.primetherapeutics.com/news/study-finds-number-of-asthma-biologic-medication-users-and-spend-doubled-over-2-5-years/